Published in J Virol on May 01, 1995
Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer (2003) 8.01
Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology (2010) 7.24
Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol (1999) 6.45
Highly effective detection of human papillomavirus 16 and 18 DNA by a testing algorithm combining broad-spectrum and type-specific PCR. J Clin Microbiol (2006) 3.34
Papillomavirus capsid protein expression level depends on the match between codon usage and tRNA availability. J Virol (1999) 2.35
Detection and typing of human papillomavirus by e6 nested multiplex PCR. J Clin Microbiol (2004) 2.34
Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments. J Virol (1995) 2.13
Assessment of the serological relatedness of genital human papillomaviruses by hemagglutination inhibition. J Virol (1996) 1.94
Genotyping of human papillomavirus in liquid cytology cervical specimens by the PGMY line blot assay and the SPF(10) line probe assay. J Clin Microbiol (2002) 1.94
Molecular and mutation trends analyses of omp1 alleles for serovar E of Chlamydia trachomatis. Implications for the immunopathogenesis of disease. J Clin Invest (1997) 1.93
Assessment of MagNA pure LC extraction system for detection of human papillomavirus (HPV) DNA in PreservCyt samples by the Roche AMPLICOR and LINEAR ARRAY HPV tests. J Clin Microbiol (2006) 1.78
Life cycle heterogeneity in animal models of human papillomavirus-associated disease. J Virol (2002) 1.66
Intratype variation in 12 human papillomavirus types: a worldwide perspective. J Virol (1996) 1.65
Detection of human papillomavirus DNA and oncoprotein overexpression are associated with distinct morphological patterns of tonsillar squamous cell carcinoma. Am J Pathol (1998) 1.64
Contamination of environmental surfaces by genital human papillomaviruses. Sex Transm Infect (2002) 1.60
High prevalence of cutaneous human papillomavirus DNA on the top of skin tumors but not in "Stripped" biopsies from the same tumors. J Invest Dermatol (2004) 1.48
Degenerate and nested PCR: a highly sensitive and specific method for detection of human papillomavirus infection in cutaneous warts. J Clin Microbiol (1999) 1.46
comparison of two commercial assays for detection of human papillomavirus (HPV) in cervical scrape specimens: validation of the Roche AMPLICOR HPV test as a means to screen for HPV genotypes associated with a higher risk of cervical disorders. J Clin Microbiol (2005) 1.44
Persistence of human papillomavirus DNA in benign and (pre)malignant skin lesions from renal transplant recipients. J Clin Microbiol (2000) 1.44
Healthy skin of many animal species harbors papillomaviruses which are closely related to their human counterparts. J Virol (2002) 1.40
Identification of two cross-neutralizing linear epitopes within the L1 major capsid protein of human papillomaviruses. J Virol (2002) 1.35
Phylogenetic incongruence among oncogenic genital alpha human papillomaviruses. J Virol (2005) 1.34
Mucosal human papillomaviruses encode four different E5 proteins whose chemistry and phylogeny correlate with malignant or benign growth. J Virol (2004) 1.34
General acquisition of human papillomavirus infections of skin occurs in early infancy. J Clin Microbiol (2003) 1.33
Induction of antitumor immunity in vivo following delivery of a novel HPV-16 DNA vaccine encoding an E6/E7 fusion antigen. Vaccine (2008) 1.28
Variation of human papillomavirus type 6 (HPV-6) and HPV-11 genomes sampled throughout the world. J Clin Microbiol (1995) 1.25
Short fragment polymerase chain reaction reverse hybridization line probe assay to detect and genotype a broad spectrum of human papillomavirus types. Clinical evaluation and follow-up. Am J Pathol (1999) 1.23
Worldwide genomic diversity of the high-risk human papillomavirus types 31, 35, 52, and 58, four close relatives of human papillomavirus type 16. J Virol (2005) 1.22
Identification of a G(2) arrest domain in the E1 wedge E4 protein of human papillomavirus type 16. J Virol (2002) 1.21
Cervical human papillomavirus infection and squamous intraepithelial lesions in rural Gambia, West Africa: viral sequence analysis and epidemiology. Br J Cancer (2005) 1.18
The viral E4 protein is required for the completion of the cottontail rabbit papillomavirus productive cycle in vivo. J Virol (2004) 1.18
Human papillomavirus (HPV) types 101 and 103 isolated from cervicovaginal cells lack an E6 open reading frame (ORF) and are related to gamma-papillomaviruses. Virology (2006) 1.16
Cellular immunity induced by a novel HPV18 DNA vaccine encoding an E6/E7 fusion consensus protein in mice and rhesus macaques. Vaccine (2008) 1.16
Genomic diversity and evolution of papillomaviruses in rhesus monkeys. J Virol (1997) 1.16
Amino acids critical for the functions of the bovine papillomavirus type 1 E2 transactivator. J Virol (1996) 1.14
Avian papillomaviruses: the parrot Psittacus erithacus papillomavirus (PePV) genome has a unique organization of the early protein region and is phylogenetically related to the chaffinch papillomavirus. BMC Microbiol (2002) 1.11
Human papillomavirus and the development of non-melanoma skin cancer. J Clin Pathol (1999) 1.09
Facile, comprehensive, high-throughput genotyping of human genital papillomaviruses using spectrally addressable liquid bead microarrays. J Mol Diagn (2005) 1.07
Detection and typing of human papillomaviruses in mucosal and cutaneous biopsies from immunosuppressed and immunocompetent patients and patients with epidermodysplasia verruciformis: a unified diagnostic approach. J Clin Pathol (1998) 1.06
Detection of human papillomavirus DNA in urine specimens from human immunodeficiency virus-positive women. J Clin Microbiol (2002) 1.05
DNA-EIA to detect high and low risk HPV genotypes in cervical lesions with E6/E7 primer mediated multiplex PCR. J Clin Pathol (1998) 1.04
Persistent antibodies to HPV virus-like particles following natural infection are protective against subsequent cervicovaginal infection with related and unrelated HPV. Viral Immunol (2009) 1.03
Evaluation of combined general primer-mediated PCR sequencing and type-specific PCR strategies for determination of human papillomavirus genotypes in cervical cell specimens. J Clin Microbiol (2007) 1.02
Molecular events in uterine cervical cancer. Sex Transm Infect (1998) 1.01
A human papilloma virus testing algorithm comprising a combination of the L1 broad-spectrum SPF10 PCR assay and a novel E6 high-risk multiplex type-specific genotyping PCR assay. J Clin Microbiol (2013) 0.95
Measuring effectiveness of the cervical cancer vaccine in an Australian setting (the VACCINE study). BMC Cancer (2013) 0.94
Identification of a novel human gammapapillomavirus species. J Gen Virol (2009) 0.93
Analysis of host-parasite incongruence in papillomavirus evolution using importance sampling. Mol Biol Evol (2010) 0.92
A novel genital human papillomavirus (HPV), HPV type 74, found in immunosuppressed patients. J Clin Microbiol (1996) 0.91
Analysis of CD4(+) T-cell responses to human papillomavirus (HPV) type 11 L1 in healthy adults reveals a high degree of responsiveness and cross-reactivity with other HPV types. J Virol (2002) 0.90
Identification of six putative novel human papillomaviruses (HPV) and characterization of candidate HPV type 87. J Virol (2001) 0.88
From Human Papillomavirus (HPV) Detection to Cervical Cancer Prevention in Clinical Practice. Cancers (Basel) (2014) 0.86
Development and clinical evaluation of a highly sensitive DNA microarray for detection and genotyping of human papillomaviruses. J Clin Microbiol (2004) 0.86
Prevention of cervical, vaginal, and vulval cancers: role of the quadrivalent human papillomavirus (6, 11, 16, 18) recombinant vaccine. Int J Womens Health (2010) 0.84
Recent advances in the search for antiviral agents against human papillomaviruses. Antivir Ther (2007) 0.79
Molecular cloning and nucleotide sequence analysis of a novel human papillomavirus (Type 82) associated with vaginal intraepithelial neoplasia. Clin Diagn Lab Immunol (2000) 0.79
Human Papillomavirus (HPV) Prevalence in Nasal and Antrochoanal Polyps and Association with Clinical Data. PLoS One (2015) 0.79
Expression and in Silico analysis of the recombinant bovine papillomavirus E6 protein as a model for viral oncoproteins studies. Biomed Res Int (2013) 0.78
Genome sequencing accuracy by RCA-seq versus long PCR template cloning and sequencing in identification of human papillomavirus type 58. Cell Biosci (2014) 0.77
HPV Population Profiling in Healthy Men by Next-Generation Deep Sequencing Coupled with HPV-QUEST. Viruses (2016) 0.77
The role of vaccines in the control of STDs: HPV vaccines. Genitourin Med (1996) 0.77
Human papillomavirus type 16 variants in cervical intraepithelial neoplasia and invasive carcinoma in San Luis Potosí City, Mexico. Infect Agent Cancer (2009) 0.77
Retrospective analysis of HPV 16/18-related disease burden using archival clinical samples. J Cancer Res Clin Oncol (2016) 0.76
Human papilloma virus (HPV) vaccination in childhood: challenges and perspectives. Hippokratia (2011) 0.76
Prevalence of human papillomavirus type 58 in women with or without cervical lesions in northeast Brazil. Ann Med Health Sci Res (2013) 0.75
Detecting genomic regions associated with a disease using variability functions and Adjusted Rand Index. BMC Bioinformatics (2011) 0.75
Bovine papillomavirus in Brazil: detection of coinfection of unusual types by a PCR-RFLP method. Biomed Res Int (2013) 0.75
Signature sequence validation of human papillomavirus type 16 (HPV-16) in clinical specimens. J Clin Pathol (2009) 0.75
Cervical HPV type-specific pre-vaccination prevalence and age distribution in Croatia. PLoS One (2017) 0.75
Genome Sequence of Human Papillomavirus 23 Strain HPV-23/Lancaster/2015. Genome Announc (2017) 0.75
Genome Sequence of Human Papillomavirus Type 20, Strain HPV-20/Lancaster/2015. Genome Announc (2017) 0.75
Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol (1992) 7.14
The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A. Cell (1988) 6.28
Heterogeneity of the human papillomavirus group. J Virol (1989) 4.90
Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J Infect Dis (1994) 4.89
Viruses in human cancers. Science (1991) 4.58
Application and accuracy of molecular phylogenies. Science (1994) 4.48
Cloning of cDNAs for cellular proteins that bind to the retinoblastoma gene product. Nature (1991) 3.20
Multiple aligned sequence editor (MASE). Trends Biochem Sci (1988) 3.11
Structural and mutational analysis of E2 trans-activating proteins of papillomaviruses reveals three distinct functional domains. EMBO J (1988) 3.01
A common function for polyoma virus large-T and papillomavirus E1 proteins? Nature (1984) 2.96
Phylogenetic classification of human papillomaviruses: correlation with clinical manifestations. J Gen Virol (1992) 2.56
Human pathogenic papillomavirus types: an update. Curr Top Microbiol Immunol (1994) 2.50
The powers and pitfalls of parsimony. Nature (1993) 2.47
Nested PCR approach for detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients. J Clin Microbiol (1995) 2.33
The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations. J Virol (1993) 2.27
Genital human papillomavirus infection. Proc Natl Acad Sci U S A (1994) 2.12
The human papillomavirus type 16 E2 transcription factor binds with low cooperativity to two flanking sites and represses the E6 promoter through displacement of Sp1 and TFIID. J Virol (1994) 2.01
Evolution of human papillomavirus type 18: an ancient phylogenetic root in Africa and intratype diversity reflect coevolution with human ethnic groups. J Virol (1993) 1.99
Phylogenetic analysis of 48 papillomavirus types and 28 subtypes and variants: a showcase for the molecular evolution of DNA viruses. J Virol (1992) 1.88
Phylogenetic trees support the coevolution of parasites and their hosts. Nature (1988) 1.83
Coevolution of papillomaviruses with human populations. Trends Microbiol (1994) 1.62
Biochemical characterization of two types of human papillomaviruses associated with epidermodysplasia verruciformis. J Virol (1982) 1.58
Specific types of human papillomavirus found in benign proliferations and carcinomas of the skin in immunosuppressed patients. Cancer Res (1994) 1.51
Characterization of a novel human papillomavirus DNA in the cervical carcinoma cell line ME180. J Virol (1991) 1.42
Primer-directed sequencing of human papillomavirus types. Curr Top Microbiol Immunol (1994) 1.37
Nucleotide and amino acid sequence variation in the L1 and E7 open reading frames of human papillomavirus type 6 and type 16. Virology (1991) 1.30
Geographical dependence of sequence variation in the E7 gene of human papillomavirus type 16. J Gen Virol (1992) 1.25
Genetic heterogeneity among human papillomaviruses (HPV) associated with epidermodysplasia verruciformis: evidence for multiple allelic forms of HPV5 and HPV8 E6 genes. Virology (1991) 1.18
Coevolution of persistently infecting small DNA viruses and their hosts linked to host-interactive regulatory domains. Proc Natl Acad Sci U S A (1993) 1.16
Epidermodysplasia verruciformis: immunological and clinical aspects. Curr Top Microbiol Immunol (1994) 1.14
Epidermodysplasia verruciformis associated human papillomaviruses present a subgenus-specific organization of the regulatory genome region. Nucleic Acids Res (1990) 1.14
Evolution of papillomaviruses. Curr Top Microbiol Immunol (1994) 1.09
The B subgroup bovine papillomaviruses lack an identifiable E6 open reading frame. Mol Carcinog (1991) 1.06
Sequence variation in the capsid protein genes of human papillomavirus type 16. J Gen Virol (1994) 1.05
Genetic heterogeneity of oncogenic human papillomavirus type 5 (HPV5) and phylogeny of HPV5 variants associated with epidermodysplasia verruciformis. J Clin Microbiol (1993) 1.02
A subtype of human papillomavirus 5 (HPV-5b) and its subgenomic segment amplified in a carcinoma: nucleotide sequences and genomic organizations. Virology (1991) 0.97
Sequence rearrangements in the upstream regulatory region of human papillomavirus type 6: are these involved in malignant transition? J Gen Virol (1994) 0.96
Genome of an avian papillomavirus. J Virol (1984) 0.95
Two novel types of human papillomavirus, HPV 63 and HPV 65: comparisons of their clinical and histological features and DNA sequences to other HPV types. Virology (1993) 0.95
In vitro transformation and molecular characterization of Colobus monkey venereal papillomavirus DNA. Virology (1991) 0.92
Nucleotide sequence of human papillomavirus (HPV) type 41: an unusual HPV type without a typical E2 binding site consensus sequence. Virus Res (1991) 0.88
Primary structure of the E6 protein of Micromys minutus papillomavirus and Mastomys natalensis papillomavirus. Nucleic Acids Res (1992) 0.83
A whole-genome assembly of Drosophila. Science (2000) 38.48
Weighted neighbor joining: a likelihood-based approach to distance-based phylogeny reconstruction. Mol Biol Evol (2000) 15.03
Mapping the DNA fragments produced by cleavage by lambda DNA with endonuclease RI. Nature (1973) 9.21
Nucleotide sequence of cdna coding for Semliki Forest virus membrane glycoproteins. Nature (1980) 8.07
Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction. Nature (1998) 8.02
Specificity of the break produced by restricting endonuclease R 1 in Simian virus 40 DNA, as revealed by partial denaturation mapping. Proc Natl Acad Sci U S A (1972) 6.87
A DNA-unwinding protein isolated from Escherichia coli: its interaction with DNA and with DNA polymerases. Proc Natl Acad Sci U S A (1972) 5.83
Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J Infect Dis (1994) 4.89
12-O-tetradecanoyl-phorbol-13-acetate induction of the human collagenase gene is mediated by an inducible enhancer element located in the 5'-flanking region. Mol Cell Biol (1987) 4.86
Characterization by electron microscopy of the complex formed between T4 bacteriophage gene 32-protein and DNA. J Mol Biol (1972) 4.46
A partial denaturation map of herpes simplex virus type 1 DNA: evidence for inversions of the unique DNA regions. J Gen Virol (1976) 4.45
Construction of a fusion gene that confers resistance against hygromycin B to mammalian cells in culture. Exp Cell Res (1985) 4.42
Cleavage maps of DNA from adenovirus types 2 and 5 by restriction endonucleases EcoRI and HpaI. Cold Spring Harb Symp Quant Biol (1975) 3.87
Design of a compartmentalized shotgun assembler for the human genome. Bioinformatics (2001) 3.55
Isolation of a genomic clone partially encoding human hypoxanthine phosphoribosyltransferase. Proc Natl Acad Sci U S A (1982) 3.49
B104, a new dispersed repeated gene family in Drosophila melanogaster and its analogies with retroviruses. J Mol Biol (1982) 3.31
The capsid protein of Semliki Forest virus has clusters of basic amino acids and prolines in its amino-terminal region. Proc Natl Acad Sci U S A (1980) 3.26
Silencing of TGF-beta signalling by the pseudoreceptor BAMBI. Nature (1999) 3.16
Coronavirus mRNA synthesis involves fusion of non-contiguous sequences. EMBO J (1983) 3.13
Ribosomal proteins of Escherichia coli. II. Proteins from the 30 s subunit. J Mol Biol (1968) 3.08
Comparison of Epstein-Barr virus strains of different origin by analysis of the viral DNAs. J Virol (1980) 3.00
Construction of plasmid cloning vehicles that promote gene expression from the bacteriophage lambda pL promoter. Gene (1979) 3.00
Analysis of cosmids using linearization by phage lambda terminase. Gene (1985) 2.98
Structure of Herpesvirus saimiri genomes: arrangement of heavy and light sequences in the M genome. J Virol (1976) 2.87
A computer program designed to screen rapidly for HIV type 1 intersubtype recombinant sequences. AIDS Res Hum Retroviruses (1995) 2.78
Heterogeneity of Epstein-Barr virus. III. Comparison of a transforming and a nontransforming virus by partial denaturation mapping of their DNAs. J Virol (1978) 2.78
Use of the lambda phage promoter PL to promote gene expression in hybrid plasmid cloning vehicles. Methods Enzymol (1979) 2.74
Structure and molecular weight of the 60-70S RNA and the 30-40S RNA of the Rous sarcoma virus. Proc Natl Acad Sci U S A (1974) 2.60
Structure of the replicating DNA from bacteriophage T4. Proc Natl Acad Sci U S A (1971) 2.59
Molecular weight determination of Sendai and Newcastle disease virus RNA. J Virol (1974) 2.45
Dickkopf genes are co-ordinately expressed in mesodermal lineages. Mech Dev (1999) 2.36
Gene expression screening in Xenopus identifies molecular pathways, predicts gene function and provides a global view of embryonic patterning. Mech Dev (1998) 2.34
Halobacterium halobium phage øH. EMBO J (1982) 2.32
Insertion of retrovirus into the first intron of alpha 1(I) collagen gene to embryonic lethal mutation in mice. Proc Natl Acad Sci U S A (1984) 2.30
Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments. J Virol (1995) 2.13
Isolation and characterization of gene 5 protein of filamentous bacterial viruses. J Mol Biol (1972) 2.11
A putative transforming gene of Jijoye virus differs from that of Epstein-Barr virus prototypes. Virology (1985) 2.07
Mutual antagonism between dickkopf1 and dickkopf2 regulates Wnt/beta-catenin signalling. Curr Biol (2001) 2.06
The isolation of DNA from agarose gels by electrophoretic elution onto malachite green-polyacrylamide columns. Gene (1978) 2.05
Electron microscopic analysis of in vitro transcriptional complexes: mapping of promoters of the coliphage T5 genome. Mol Gen Genet (1978) 2.03
Ribosomal proteins of Escherichia coli. I. Demonstration of different primary structures. Proc Natl Acad Sci U S A (1967) 2.03
Length measurements of RNA synthesized in vitro by Escherichia coli RNA polymerase. J Mol Biol (1973) 2.02
The human papillomavirus type 16 E2 transcription factor binds with low cooperativity to two flanking sites and represses the E6 promoter through displacement of Sp1 and TFIID. J Virol (1994) 2.01
New cosmid vectors developed for eukaryotic DNA cloning. Gene (1984) 1.97
Cell cycle regulation of the murine cyclin E gene depends on an E2F binding site in the promoter. Mol Cell Biol (1996) 1.97
Human adeno-associated virus type 5 is only distantly related to other known primate helper-dependent parvoviruses. J Virol (1999) 1.94
The human papillomavirus type 16 E6 oncoprotein can down-regulate p53 activity by targeting the transcriptional coactivator CBP/p300. J Virol (1999) 1.94
Nucleotide sequence of the immunity region of bacteriophage Mu. Mol Gen Genet (1982) 1.92
Structure of gene and pseudogenes of human apoferritin H. Nucleic Acids Res (1986) 1.91
TIF-IA, the factor mediating growth-dependent control of ribosomal RNA synthesis, is the mammalian homolog of yeast Rrn3p. EMBO Rep (2000) 1.91
Letter: Electron microscopic visualization of the folded chromosome of Escherichia coli. J Mol Biol (1974) 1.90
The nucleotide sequence of Saccharomyces cerevisiae chromosome XII. Nature (1997) 1.89
Phylogenetic analysis of 48 papillomavirus types and 28 subtypes and variants: a showcase for the molecular evolution of DNA viruses. J Virol (1992) 1.88
Two deletions in the Epstein-Barr virus genome of the Burkitt lymphoma nonproducer line Raji. Virology (1984) 1.85
Ribosomal proteins of E. Coli: stoichiometry and implications for ribosome structure. Cold Spring Harb Symp Quant Biol (1969) 1.83
Progesterone and glucocorticoid response elements occur in the long control regions of several human papillomaviruses involved in anogenital neoplasia. J Virol (1989) 1.83
Transcriptional activation of human papillomavirus 16 by nuclear factor I, AP1, steroid receptors and a possibly novel transcription factor, PVF: a model for the composition of genital papillomavirus enhancers. Nucleic Acids Res (1990) 1.81
Genetic recombination can generate altered restriction specificity. Proc Natl Acad Sci U S A (1984) 1.79
Risk of cervical cancer and geographical variations of human papillomavirus 16 E6 polymorphisms. Lancet (1998) 1.78
Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. Cancer Res (1998) 1.75
A complex pattern of evolutionary conservation and alternative polyadenylation within the long 3"-untranslated region of the methyl-CpG-binding protein 2 gene (MeCP2) suggests a regulatory role in gene expression. Hum Mol Genet (1999) 1.70
During negative regulation of the human papillomavirus-16 E6 promoter, the viral E2 protein can displace Sp1 from a proximal promoter element. Nucleic Acids Res (1992) 1.69
Electron microscope measurements of rous sarcoma virus RNA. Cold Spring Harb Symp Quant Biol (1975) 1.69
Antagonizing the Spemann organizer: role of the homeobox gene Xvent-1. EMBO J (1995) 1.69
The E6/E7 promoter of human papillomavirus type 16 is activated in the absence of E2 proteins by a sequence-aberrant Sp1 distal element. J Virol (1990) 1.68
Analysis of cytomorphologically abnormal cervical scrapes for the presence of 27 mucosotropic human papillomavirus genotypes, using polymerase chain reaction. Int J Cancer (1994) 1.67
Potential drugs against cervical cancer: zinc-ejecting inhibitors of the human papillomavirus type 16 E6 oncoprotein. J Natl Cancer Inst (1999) 1.62
The nucleotide sequence of Saccharomyces cerevisiae chromosome XVI. Nature (1997) 1.58
Sequence variants of human papillomavirus type 16 in clinical samples permit verification and extension of epidemiological studies and construction of a phylogenetic tree. J Clin Microbiol (1991) 1.57
Topological bias and inconsistency of maximum likelihood using wrong models. Mol Biol Evol (1999) 1.55
Herpesvirus ateles DNA and its homology with Herpesvirus saimiri nucleic acid. J Virol (1978) 1.53
Duplication and transcription of procyclin genes in Trypanosoma brucei. Nucleic Acids Res (1989) 1.52
Transcription of the transforming genes of the oncogenic human papillomavirus-16 is stimulated by tumor promotors through AP1 binding sites. Nucleic Acids Res (1990) 1.51
Clusters of nuclear factor I binding sites identify enhancers of several papillomaviruses but alone are not sufficient for enhancer function. Nucleic Acids Res (1989) 1.50
Bmp-4 acts as a morphogen in dorsoventral mesoderm patterning in Xenopus. Development (1997) 1.49
Overexpression of nonconvertible PrPc delta114-121 in scrapie-infected mouse neuroblastoma cells leads to trans-dominant inhibition of wild-type PrP(Sc) accumulation. J Virol (1998) 1.49
Analysis of Mycoplasma hyorhinis genome by use of restriction endonucleases and by electron microscopy. J Bacteriol (1982) 1.48
Participation of Escherichia coli DNA in the replication of temperate bacteriophage Mu1. Virology (1974) 1.45
Two distant regions of the Epstein-Barr virus genome with sequence homologies have the same orientation and involve small tandem repeats. EMBO J (1982) 1.43
Physician involvement in capital punishment. N Y State J Med (1991) 1.42
Characterization of a novel human papillomavirus DNA in the cervical carcinoma cell line ME180. J Virol (1991) 1.42
Electron microscopic studies on the folded chromosome of Escherichia coli. Cold Spring Harb Symp Quant Biol (1974) 1.41
Animal experimentation for medical research. N Y State J Med (1989) 1.39
Specific fragmentation of DNA of adenovirus serotypes 3, 5, 7, and 12, and adeno-simian virus 40 hybrid virus Ad2+ND1 by restriction endonuclease R.EcoRI. J Virol (1974) 1.39
Infectious nucleic acids of Escherichia coli bacteriophages. 10. Preparation and properties of Escherichia coli competent for infectious DNA from bacteriophages phi X 174 and M 13 and RNA from bacteriophage M 12. Eur J Biochem (1967) 1.37
Characterization of the spliced pol transcript of feline foamy virus: the splice acceptor site of the pol transcript is located in gag of foamy viruses. J Virol (1996) 1.35
A bovine papilloma virus vector with a dominant resistance marker replicates extrachromosomally in mouse and E. coli cells. EMBO J (1983) 1.33
Intervening sequences in chloroplast genomes. Cell (1984) 1.33
Nine introns with conserved boundary sequences in the Euglena gracilis chloroplast ribulose-1,5-bisphosphate carboxylase gene. Cell (1984) 1.32
The chromatin structure of the long control region of human papillomavirus type 16 represses viral oncoprotein expression. J Virol (1999) 1.32
Characterization of the genome of feline foamy virus and its proteins shows distinct features different from those of primate spumaviruses. J Virol (1997) 1.32
Nuclear factor I and epithelial cell-specific transcription of human papillomavirus type 16. J Virol (1993) 1.31
The Xvent-2 homeobox gene is part of the BMP-4 signalling pathway controlling [correction of controling] dorsoventral patterning of Xenopus mesoderm. Development (1996) 1.31
High Sp1/Sp3 ratios in epithelial cells during epithelial differentiation and cellular transformation correlate with the activation of the HPV-16 promoter. Virology (1996) 1.27
Structure of the hepatitis B virus genome. J Virol (1983) 1.27
Single-stranded DNA structure and DNA polymerase activity in the presence of nucleic acid helix-unwinding proteins from calf thymus. J Biol Chem (1976) 1.26